These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29688817)

  • 1. Current Status of Messenger RNA Delivery Systems.
    Stanton MG
    Nucleic Acid Ther; 2018 Jun; 28(3):158-165. PubMed ID: 29688817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.
    Dowdy SF; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):107-108. PubMed ID: 29782220
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid nanoparticles for gene delivery.
    Zhao Y; Huang L
    Adv Genet; 2014; 88():13-36. PubMed ID: 25409602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.
    Kulkarni JA; Cullis PR; van der Meel R
    Nucleic Acid Ther; 2018 Jun; 28(3):146-157. PubMed ID: 29683383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.
    Phua KK
    J Immunol Res; 2015; 2015():680620. PubMed ID: 26819957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Era for Rare Genetic Diseases: Messenger RNA Therapy.
    Martini PGV; Guey LT
    Hum Gene Ther; 2019 Oct; 30(10):1180-1189. PubMed ID: 31179759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins.
    Winkler J
    Nucleic Acid Ther; 2018 Jun; 28(3):137-145. PubMed ID: 29733239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Nanoparticle Systems for Enabling Gene Therapies.
    Cullis PR; Hope MJ
    Mol Ther; 2017 Jul; 25(7):1467-1475. PubMed ID: 28412170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale platforms for messenger RNA delivery.
    Li B; Zhang X; Dong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA.
    Lui KO; Zangi L; Chien KR
    Stem Cell Res; 2014 Nov; 13(3 Pt B):693-704. PubMed ID: 25043723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlocking Delivery Strategies for mRNA Therapeutics.
    Luo Z; Chen Y
    Recent Pat Anticancer Drug Discov; 2024; 19(2):126-129. PubMed ID: 37287306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
    Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
    Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.
    Orlandini von Niessen AG; Poleganov MA; Rechner C; Plaschke A; Kranz LM; Fesser S; Diken M; Löwer M; Vallazza B; Beissert T; Bukur V; Kuhn AN; Türeci Ö; Sahin U
    Mol Ther; 2019 Apr; 27(4):824-836. PubMed ID: 30638957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles for delivery of messenger RNA to the back of the eye.
    Patel S; Ryals RC; Weller KK; Pennesi ME; Sahay G
    J Control Release; 2019 Jun; 303():91-100. PubMed ID: 30986436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish.
    Patton C; Farr GH; An D; Martini PGV; Maves L
    Zebrafish; 2018 Jun; 15(3):217-227. PubMed ID: 29369745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents.
    Turnbull IC; Eltoukhy AA; Anderson DG; Costa KD
    Methods Mol Biol; 2017; 1521():153-166. PubMed ID: 27910047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology for in vivo targeted siRNA delivery.
    Dahlman JE; Kauffman KJ; Langer R; Anderson DG
    Adv Genet; 2014; 88():37-69. PubMed ID: 25409603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.